Oncology drug franchise company in India: The need for PCD (propaganda-cum-distribution) oncology medication franchises in India is rapidly increasing. In this industry, various main drivers and trends are behind working, such as the rising cancer burden and market growth. Today, India has around 1.4-1.5 million new cancer cases each year, with forecasts suggesting a 12% increase by 2030, driven by demographic trends and lifestyle factors. Therefore, the oncology medicine industry is anticipated to be worth roughly 3,831 crore (~ USD 460 million) and is increasing at a rate of over 20%. Furthermore, a high need for affordable and generic oncology medicines is defined as many branded oncology medications lose their patents and are subject to GST-friendly pricing, and demand for lower-cost generics and biosimilars increases.
In addition, government support and greater healthcare access prove that cancer treatments are covered by programs. This includes Ayushman Bharat, which improves access in tier II/III cities and rural areas. Thus, India’s pharmaceutical sector is estimated to reach USD 130 billion by 2030, with the pharma franchisee model growing at 15-20% yearly. Most importantly, low initial investment, exclusive rights, and support from GMP/WHO-certified producers make the PCD franchise appealing. Therefore, oncology franchises provide larger profits than general medicine due to premium pricing and ongoing demand. Consequently, the PCD franchise for oncology drug market in India has several possibilities. With a growing cancer burden, government initiatives, and evolving pharmaceutical dynamics, it’s a high-demand speciality with significant growth potential. However, success is dependent on selecting dependable partners like Spica Drugs that produce high-quality products and implementing a territory-specific plan.
The top 10 important factors to consider while investing in the top oncology drug franchise company in India
Here’s a clear, complete list of crucial points to consider while investing in the leading oncology drug franchise company in India:
- Product range and portfolio: Check to see if the company offers a diverse selection of cancer products, including tablets, injections, capsules, targeted therapies, immunotherapies, and so on. Then confirm that they have WHO-GMP-certified items with the necessary DCGI approvals. This is also included with looking for firms that are constantly updating their oncology portfolio with novel medicines and combinations.
- Certification and compliance: Ensure the company adheres to tight regulatory criteria (WHO-GMP, ISO, DCGI) and then verify licenses, trademarks, and drug approvals. Also, you need to confirm compliance with Schedule M manufacturing standards.
- Monopoly and franchise rights: To avoid competition, ensure that the corporation gives exclusive monopoly rights in your area. After this, you can examine the agreement carefully for specific conditions about territory and length.
- Brand reputation: Check the oncology drug PCD franchise and choose their market reputation using reviews, client comments, and industry presence. Moreover, in the oncology area, preference should be given to established brands with significant customer trust.
- Marketing and promotional support: Good oncology franchise companies offer visual aids, MR packs, product samples, literature, doctor’s gift articles, and so on. Another important element is support for calls, doctor meetings, and digital marketing, which is an additional benefit.
- Quality assurance: Ensure the company you choose adheres to international quality standards. In addition, you need to determine whether they have an in-house QA/QC team, advanced testing labs, and current facilities.
- Supply chain and timely delivery: Oncology medicines necessitate cold chain management and specialised storage; ensure the company’s logistics are adequate. This is also included with on-time delivery, which is crucial in cancer; enquire about their inventory management and shipping schedules.
- Transparent pricing and profit margin: Examine the company’s pricing structure; it should provide adequate margins for distributors and stockists. After this, you can also check for hidden expenses such as freight, insurance, and minimum order quantities.
- Training and technical support: A reputable corporation should provide technical training on oncology products, including usage instructions, dosage, and side effects. In this, there is a huge role for the regular medical updates and training sessions, which are beneficial.
- Legal and contractual clarity: Lastly, you need to scrutinise the franchise agreement, paying special attention to clauses dealing with monopoly rights, termination, renewal, compensation, and other issues. Although keep all relevant legal documentation, including GST registration and medical licenses, readily available.
Different types of Oncology Drugs
Here is a detailed overview of our company’s oncology medicines and their benefits in cancer treatment:
- Chemotherapy medicines: These traditional anti-cancer medications kill or inhibit the proliferation of rapidly proliferating cancer cells. This includes doxorubicin, cisplatin, paclitaxel, and cyclophosphamide. These are beneficial as:
- Effective for rapidly reducing tumours.
- Frequently used before and after surgery to decrease recurrence.
- Can treat metastatic malignancies.
- Targeted therapy: This refers to medicines that target specific substances, such as proteins or genes, that contribute to cancer growth. This includes imatinib (for CML), erlotinib, and trastuzumab and is beneficial as:
- More precisely, it targets cancer cells while protecting the majority of normal cells.
- There are fewer negative effects than with chemotherapy.
- Commonly used for tumours with confirmed genetic abnormalities.
- Immunotherapy: enhances the immune system’s ability to identify and eliminate cancer cells. In this, we include Keytruda (pembrolizumab), nivolumab, and ipilimumab. These have many advantages, like
- Can produce long-term responses in certain malignancies.
- It may be effective when other treatments fail.
- Newer medications offer promise for a variety of cancer types.
- Hormonal therapy: blocks or reduces hormones that contribute to cancer and also has many examples, including tamoxifen, letrozole, anastrozole, and flutamide. These medicines are essential for hormone-sensitive malignancies, such as breast and prostate cancer. This can slow or prevent cancer growth and is also usually administered as oral tablets for months or years.
Conclusion time
Consequently, we would like to inform you that the following points should be considered when investing in the top oncology drug franchise company in India. Also, Spica Drugs is the leading brand name in this industry that offers genuine services all over the country.